Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

A. Gordon Robertson; Clarice S. Groeneveld; Brian Jordan; Xiaoqi Lin; Kimberly A. McLaughlin; Arighno Das; Leigh Ann Fall; Damiano Fantini; Timothy J. Taxter; Lauren S. Mogil; Sia Viborg Lindskrog; Lars Dyrskjøt; David J. McConkey; Robert S. Svatek; Aurélien de Reyniès; Mauro A.A. Castro; Joshua J. Meeks

doi:10.1016/j.eururo.2021.11.001

Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, Xiaoqi Lin, Kimberly A. McLaughlin, Arighno Das, Leigh Ann Fall, Damiano Fantini, Timothy J. Taxter, Lauren S. Mogil, Sia Viborg Lindskrog, Lars Dyrskjøt, David J. McConkey, Robert S. Svatek, Aurélien de Reyniès, Mauro A.A. Castro, Joshua J. Meeks^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

Original language	English (US)
Pages (from-to)	e53
Journal	European urology
Volume	81
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2021.11.001
State	Published - Feb 2022

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2021.11.001

Fingerprint

Dive into the research topics of 'Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))'. Together they form a unique fingerprint.

Cite this

Robertson, A. G., Groeneveld, C. S., Jordan, B., Lin, X., McLaughlin, K. A., Das, A., Fall, L. A., Fantini, D., Taxter, T. J., Mogil, L. S., Lindskrog, S. V., Dyrskjøt, L., McConkey, D. J., Svatek, R. S., de Reyniès, A., Castro, M. A. A., & Meeks, J. J. (2022). Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048)). European urology, 81(2), e53. https://doi.org/10.1016/j.eururo.2021.11.001

@article{84e91fc44c644c1cbba76de8d700eefa,

title = "Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))",

abstract = "In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.",

author = "Robertson, {A. Gordon} and Groeneveld, {Clarice S.} and Brian Jordan and Xiaoqi Lin and McLaughlin, {Kimberly A.} and Arighno Das and Fall, {Leigh Ann} and Damiano Fantini and Taxter, {Timothy J.} and Mogil, {Lauren S.} and Lindskrog, {Sia Viborg} and Lars Dyrskj{\o}t and McConkey, {David J.} and Svatek, {Robert S.} and {de Reyni{\`e}s}, Aur{\'e}lien and Castro, {Mauro A.A.} and Meeks, {Joshua J.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = feb,

doi = "10.1016/j.eururo.2021.11.001",

language = "English (US)",

volume = "81",

pages = "e53",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "2",

}

Robertson, AG, Groeneveld, CS, Jordan, B, Lin, X, McLaughlin, KA, Das, A, Fall, LA, Fantini, D, Taxter, TJ, Mogil, LS, Lindskrog, SV, Dyrskjøt, L, McConkey, DJ, Svatek, RS, de Reyniès, A, Castro, MAA & Meeks, JJ 2022, 'Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))', European urology, vol. 81, no. 2, pp. e53. https://doi.org/10.1016/j.eururo.2021.11.001

Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048)). / Robertson, A. Gordon; Groeneveld, Clarice S.; Jordan, Brian et al.
In: European urology, Vol. 81, No. 2, 02.2022, p. e53.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

AU - Robertson, A. Gordon

AU - Groeneveld, Clarice S.

AU - Jordan, Brian

AU - Lin, Xiaoqi

AU - McLaughlin, Kimberly A.

AU - Das, Arighno

AU - Fall, Leigh Ann

AU - Fantini, Damiano

AU - Taxter, Timothy J.

AU - Mogil, Lauren S.

AU - Lindskrog, Sia Viborg

AU - Dyrskjøt, Lars

AU - McConkey, David J.

AU - Svatek, Robert S.

AU - de Reyniès, Aurélien

AU - Castro, Mauro A.A.

AU - Meeks, Joshua J.

PY - 2022/2

Y1 - 2022/2

N2 - In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

AB - In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

UR - http://www.scopus.com/inward/record.url?scp=85120991663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120991663&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.11.001

DO - 10.1016/j.eururo.2021.11.001

M3 - Comment/debate

C2 - 34801336

AN - SCOPUS:85120991663

SN - 0302-2838

VL - 81

SP - e53

JO - European urology

JF - European urology

IS - 2

ER -

Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this